Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity, clinical trial shows

**Study Finds Diabetes Drug May Alleviate Knee Pain in Patients with Osteoarthritis and Obesity**

A clinical trial led by researchers at Monash University has found that a widely used diabetes medication may help reduce knee pain in individuals suffering from osteoarthritis who are also overweight or obese. The findings suggest the drug could potentially delay the need for knee replacement surgeries in affected patients.

The study focused on repurposing the diabetes drug to address pain associated with knee osteoarthritis, a common condition that disproportionately affects individuals with higher body weight. Researchers observed that participants who received the medication experienced notable reductions in pain levels compared to those who did not. The trial highlights the potential of existing medications to serve dual purposes, offering relief for conditions beyond their original intended use. Further research may be required to confirm these results and explore long-term implications.

Newsflash | Powered by GeneOnline AI

Source: https://medicalxpress.com/news/2025-04-repurposed-diabetes-drug-pain-knee.html

Author

Mark Chiang